194 related articles for article (PubMed ID: 23837606)
1. Value of information: interim analysis of a randomized, controlled trial of goal-directed hemodynamic treatment for aged patients.
Bartha E; Davidson T; Brodtkorb TH; Carlsson P; Kalman S
Trials; 2013 Jul; 14():205. PubMed ID: 23837606
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
[TBL] [Abstract][Full Text] [Related]
3. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
[TBL] [Abstract][Full Text] [Related]
4. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
5. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
Siebert U; Rochau U; Claxton K
Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of goal-directed hemodynamic treatment of elderly hip fracture patients: before clinical research starts.
Bartha E; Davidson T; Hommel A; Thorngren KG; Carlsson P; Kalman S
Anesthesiology; 2012 Sep; 117(3):519-30. PubMed ID: 22814385
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of goal-directed haemodynamic treatment in patients with proximal femoral fracture.
Bartha E; Arfwedson C; Imnell A; Fernlund ME; Andersson LE; Kalman S
Br J Anaesth; 2013 Apr; 110(4):545-53. PubMed ID: 23274782
[TBL] [Abstract][Full Text] [Related]
8. Towards individualized perioperative, goal-directed haemodynamic algorithms for patients of advanced age: observations during a randomized controlled trial (NCT01141894).
Bartha E; Arfwedson C; Imnell A; Kalman S
Br J Anaesth; 2016 Apr; 116(4):486-92. PubMed ID: 26994228
[TBL] [Abstract][Full Text] [Related]
9. Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.
McCullagh L; Walsh C; Barry M
Pharmacoeconomics; 2012 Oct; 30(10):941-59. PubMed ID: 22667458
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness and value of information analyses of islet cell transplantation in the management of 'unstable' type 1 diabetes mellitus.
Wallner K; Shapiro AM; Senior PA; McCabe C
BMC Endocr Disord; 2016 Apr; 16():17. PubMed ID: 27061400
[TBL] [Abstract][Full Text] [Related]
11. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
13. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial.
Majumdar SR; Lier DA; Beaupre LA; Hanley DA; Maksymowych WP; Juby AG; Bell NR; Morrish DW
Arch Intern Med; 2009 Jan; 169(1):25-31. PubMed ID: 19139320
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of screening for oral cancer in primary care.
Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
[TBL] [Abstract][Full Text] [Related]
17. Effect of postoperative goal-directed therapy in cancer patients undergoing high-risk surgery: a randomized clinical trial and meta-analysis.
Gerent ARM; Almeida JP; Fominskiy E; Landoni G; de Oliveira GQ; Rizk SI; Fukushima JT; Simoes CM; Ribeiro U; Park CL; Nakamura RE; Franco RA; Cândido PI; Tavares CR; Camara L; Dos Santos Rocha Ferreira G; de Almeida EPM; Filho RK; Galas FRBG; Hajjar LA
Crit Care; 2018 May; 22(1):133. PubMed ID: 29792232
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
van Eekelen R; Eijkemans MJ; Mochtar M; Mol F; Mol BW; Groen H; van Wely M
Hum Reprod; 2020 Sep; 35(9):2037-2046,. PubMed ID: 32876323
[TBL] [Abstract][Full Text] [Related]
19. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
20. Estimated Monetary Value of Future Research Clarifying Uncertainties Around the Optimal Adult Hearing Screening Schedule.
Borre ED; Myers ER; Dubno JR; Emmett SD; Pavon JM; Francis HW; Ogbuoji O; Sanders Schmidler GD
JAMA Health Forum; 2022 Nov; 3(11):e224065. PubMed ID: 36367737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
